Benzimidazole analogs inhibit human herpesvirus 6 |
| |
| Authors: | Prichard Mark N Frederick Samuel L Daily Shannon Borysko Katherine Z Townsend Leroy B Drach John C Kern Earl R |
| |
| Affiliation: | 1University of Alabama School of Medicine, Birmingham, Alabama;2School of Dentistry and College of Pharmacy, University of Michigan, Ann Arbor, Michigan |
| |
| Abstract: | ![]()
Several benzimidazole nucleoside analogs, including 1H-β-D-ribofuranosyl-2-bromo-5,6-dichlorobenzimidazole (BDCRB) and 1H-β-L-ribofuranosyl-2-isopropylamino-5,6-dichlorobenzimidazole (maribavir [MBV]), inhibit the replication of human cytomegalovirus. Neither analog inhibited the related betaherpesvirus human herpesvirus 6 (HHV-6). Additional analogs of these compounds were evaluated against both variants of HHV-6, and two L-analogs of BDCRB had good antiviral activity against HHV-6A, as well as more modest inhibition of HHV-6B replication. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
